600056 中国医药
2026/03 - 三个月
人民币(K¥)
2025/12
人民币(K¥)
2024/12
人民币(K¥)
2023/12
人民币(K¥)
2022/12
人民币(K¥)
经营活动产生之现金流量净额(1,421,320)1,425,8791,011,805859,0751,645,872
投资活动产生之现金流量净额(395,566)(299,607)(366,714)(316,247)22,139
筹资活动产生之现金流量净额81,186(1,604,313)(164,093)(725,654)(2,024)
汇率变动对现金及现金等价物的影响(110)(12,442)1,7802,04110,742
现金及现金等价物净增加/(减少)(1,735,811)(490,483)482,777(180,785)1,676,730
期初现金及现金等价物余额3,349,8863,840,3683,357,5913,511,0441,834,314
期末现金及现金等价物余额1,614,0753,349,8863,840,3683,330,2593,511,044